☆ 4.8 Letter

Representation of Patients With Cardiovascular Disease in Pivotal Cancer Clinical Trials

CIRCULATION (2019)

Get Full Text
Add to Collection

Journal

CIRCULATION
Volume 139, Issue 22, Pages 2594-2596

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCULATIONAHA.118.039180

Keywords

cancer; cardiovascular disease; clinical trials as topic; underrepresentation; United States Food and Drug Administration

Categories

Cardiac & Cardiovascular Systems Peripheral Vascular Disease

Funding

  1. NIH [P50-CA140158, R35-CA197734, K23-CA178183, R01-CA197870, K12-CA133250]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.